The MemorialCare Cancer Institute at Orange Coast Medical Center has received the official designation as a Community Medical Center of Excellence in lung cancer from the Bonnie J. Addario Lung Cancer Foundation (ALCF). The ALCF Center of Excellence designation recognizes hospitals and cancer centers for their individualized care and treatment of lung cancer patients.
“In receiving this prestigious designation, we continue demonstrating our commitment to providing the most advanced and clinically proven diagnostic screenings and treatments to our lung cancer patients,” explains Marcia Manker, CEO of Orange Coast Medical Center. “Lung cancer continues to be by far the leading cause of cancer death among both men and women and early and accurate detection through appropriate screening practices are critical to providing patients the best chance for beating their disease.”
The MemorialCare Cancer Institute at Orange Coast Medical Center is one of only 14 designated centers across the United States. As a Community Hospital Center of Excellence, Orange Coast Medical Center is implementing the standard of care required in the ALCF’s Centers of Excellence Program. The program’s hallmark standard ensures all patients receive genomic testing to monitor for specific disease states and to determine potential options for precision medicine and targeted treatment. Additional standards include an individualized approach to care, patient access to new diagnostic tools and therapeutic techniques, and an emphasis on early detection and patient follow-up.
"Lung cancer is a very complex and aggressive cancer. It takes the multi-disciplinary care and tireless commitment of a team of lung cancer specialists to deliver the needed complex and aggressive treatment to achieve the best possible outcome for every individual with lung cancer. With the newer targeted therapies and now immune therapy, we are seeing outcomes and survivals that those of us who are lung cancer specialists have never seen before,” said Jack Jacoub, MD, medical oncologist and medical director of MemorialCare Cancer Institute at Orange Coast Medical Center. “While we continue to make significant progress in the treatment of this disease, the highest cure rate comes from early detection through low-dose chest CT lung cancer screening.”
While the understanding of lung cancer’s diagnosis and treatment has improved, additional work is still needed to advance the treatment options and survival statistics. Approximately 221,200 new lung cancer cases were diagnosed in the U.S. in 2015.
- Lung cancer takes more lives than breast, prostate and colon cancers combined. It accounts for 27 percent of all cancer deaths and is the second leading cause of death in the U.S.
- Lung cancer is the leading cancer killer in every ethnic group. Since 1987, it has killed more women every year than breast cancer.
- Non-smokers with lung cancer is the number six cause of cancer death in the United States.
- The five-year lung cancer survival rate has changed little in nearly 40 years – from 12 percent in 1970 to 17 percent today.
“More than 80 percent of lung cancer patients in the U.S. are treated in the community hospital setting,” said Bonnie J. Addario, a Stage IIIB lung cancer survivor and founder of the ALCF. “Our multi-disciplinary, patient-centric Centers of Excellence Program raises the bar on the standard of care for lung cancer patients and ensures patients know which hospitals are using the most up-to-date technology to improve treatment options and quality of life.”
About the Bonnie J. Addario Lung Cancer Foundation
The Bonnie J. Addario Lung Cancer Foundation (ALCF) is one of the largest philanthropies (patient-founded, patient-focused, and patient-driven) devoted exclusively to eradicating Lung Cancer through research, early detection, education, and treatment. The Foundation’s goal is to work with a diverse group of physicians, organizations, industry partners, individuals, patients, survivors, and their families to identify solutions, make timely and meaningful change, and turn lung cancer into a chronically managed disease by 2023. Established on March 1, 2006 as a 501c(3) non-profit organization, the ALCF received the highest rating from Charity Navigator in 2015. The organization has raised nearly $30 million for lung cancer research and related programs.